Skip to content

Virtual Lifestyle Medicine Group Visits for High Blood Pressure

A Scalable, Lifestyle Medicine Intervention for Hypertension Using Virtual Group Shared Medical Appointments

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07698509
Enrollment
18
Registered
2026-07-13
Start date
2026-08-03
Completion date
2027-02-07
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

high blood pressure, Lifestyle medicine shared medical appointments (LMSMAs)

Brief summary

The purpose of this study is to learn whether virtual Lifestyle medicine shared medical appointments (LMSMAs) can help people better manage their blood pressure and improve their overall health.

Interventions

BEHAVIORALLifestyle Medicine Virtual group

Participants will be given a home BP monitor upon enrollment and the group will engage in twice monthly virtual shared medical appointments (vSMAs) for 4 visits. Prior to each visit, participants will be asked to complete home BP monitoring (twice in the morning and twice in the evening for 3 days before visit), with readings reviewed during visits and medications adjusted as clinically indicated. Participants will complete four sessions over an 8-week period, with one session type offered in each 2 week block.

BEHAVIORALUsual Care Group

Participants will be given a home BP monitor upon enrollment and will be instructed by phone and with an electronic health record (EHR) portal message on proper technique for home BP readings. Participants will continue to have follow-up visits with their PCP as clinically indicated.

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Current diagnosis of hypertension (ICD codes I10.0-I14.0 billed within the last 5 years Essential HTN, Essential HTN, Primary HTN) * Currently receives care at a UTPhysicians; Last seen by a PCP at Victory location within the last 1 year. * Able to participate in a virtual format * Willingness to participate and engage in home blood pressure monitoring

Exclusion criteria

* Unstable cardiovascular disease (recent Myocardial Infarction (MI), unstable angina, decompensated HF) * Advanced Chronic kidney disease (CKD) (eGFR \< 30) without nephrology co-management * Active cancer treatment * Severe cognitive impairment (unable to engage) * Uncontrolled psychiatric illness (e.g., active psychosis) * Resistant hypertension (requiring\> 3 medications at maximum doses) * Unable to participate in English class format * Unstable internet or lack of smartphone

Design outcomes

Primary

MeasureTime frame
Change in diastolic blood pressure readings2-4 weeks after randomization,6 months after randomization
Change in systolic blood pressure readings2-4 weeks after randomization,6 months after randomization

Secondary

MeasureTime frame
Percentage of eligible participants who agree to participateend of study (6 months after randomization)
Number of primary care physicians (PCPs) whose patients are included in the programend of study (6 months after randomization)
Median number of sessions attended by each participantend of study (6 months after randomization)
Adherence as assessed by the number of of blood pressure (BP) readings submitted between each sessionend of study (6 months after randomization)
Adherence to home BP monitoring as assessed by the number of of home BP sessions submitted between each sessionend of study (6 months after randomization)

Countries

United States

Contacts

CONTACTPuja B Gandhi, MD, MPH, DipABLM
Puja.Gandhi@uth.tmc.edu(713) 500-6714
CONTACTNatalia Williams
Natalia.Williams@uth.tmc.edu(713) 486-3844
PRINCIPAL_INVESTIGATORPuja B Gandhi, MD, MPH, DipABLM

The University of Texas Health Science Center, Houston

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 14, 2026